FI932561A0 - Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning - Google Patents
Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellningInfo
- Publication number
- FI932561A0 FI932561A0 FI932561A FI932561A FI932561A0 FI 932561 A0 FI932561 A0 FI 932561A0 FI 932561 A FI932561 A FI 932561A FI 932561 A FI932561 A FI 932561A FI 932561 A0 FI932561 A0 FI 932561A0
- Authority
- FI
- Finland
- Prior art keywords
- protein
- pharyngeal
- intact epithelium
- variants
- epithelium
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38654—Preparations containing enzymes, e.g. protease or amylase containing oxidase or reductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP90610072 | 1990-12-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI932561A FI932561A (fi) | 1993-06-04 |
FI932561A0 true FI932561A0 (fi) | 1993-06-04 |
Family
ID=8205875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI932561A FI932561A0 (fi) | 1990-12-05 | 1993-06-04 | Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0561907B1 (fi) |
JP (3) | JP3355186B2 (fi) |
KR (1) | KR100237968B1 (fi) |
AT (1) | ATE170630T1 (fi) |
AU (1) | AU9052891A (fi) |
BR (1) | BR9107206A (fi) |
CA (2) | CA2331936C (fi) |
DE (1) | DE69130113T2 (fi) |
DK (1) | DK0561907T3 (fi) |
FI (1) | FI932561A0 (fi) |
WO (1) | WO1992010755A1 (fi) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU682314B2 (en) * | 1992-07-17 | 1997-10-02 | Genencor International, Inc. | High alkaline serine proteases |
WO1996012186A1 (en) * | 1994-10-14 | 1996-04-25 | Chiron Mimotopes Pty. Ltd. | Method and apparatus for efficient mimotope discovery |
JP2001511162A (ja) | 1997-02-06 | 2001-08-07 | ノボ ノルディスク アクティーゼルスカブ | 付加され、そして/又は除去された付着基を有するポリペプチド−ポリマー結合体 |
US6284246B1 (en) | 1997-07-30 | 2001-09-04 | The Procter & Gamble Co. | Modified polypeptides with high activity and reduced allergenicity |
AU2003203147B2 (en) | 1998-03-23 | 2008-05-29 | Novozymes A/S | Phytase variants |
US6495136B1 (en) | 1998-03-26 | 2002-12-17 | The Procter & Gamble Company | Proteases having modified amino acid sequences conjugated to addition moieties |
KR20010052223A (ko) * | 1998-03-26 | 2001-06-25 | 데이비드 엠 모이어 | 아미노산 결실 및 치환을 갖는 세린 프로테아제 변이체 |
JP2002507426A (ja) | 1998-03-26 | 2002-03-12 | ザ、プロクター、エンド、ギャンブル、カンパニー | アミノ酸置換を有するセリンプロテアーゼ変異体 |
US6908757B1 (en) | 1998-03-26 | 2005-06-21 | The Procter & Gamble Company | Serine protease variants having amino acid deletions and substitutions |
US6835550B1 (en) * | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
US6642011B2 (en) | 1998-04-15 | 2003-11-04 | Genencor International, Inc. | Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
US6838269B1 (en) | 1998-04-15 | 2005-01-04 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US6936249B1 (en) | 1998-04-15 | 2005-08-30 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US6461849B1 (en) * | 1998-10-13 | 2002-10-08 | Novozymes, A/S | Modified polypeptide |
NZ511291A (en) | 1998-10-30 | 2003-08-29 | Novozymes As | A method for selecting a protein variant that has reduced immunogenicity as compared with the parent or wild-type protein |
US6686164B1 (en) | 1998-10-30 | 2004-02-03 | Novozymes A/S | Low allergenic protein variants |
EP1051432B1 (en) * | 1998-12-08 | 2007-01-24 | Biovation Limited | Method for reducing immunogenicity of proteins |
KR20020021396A (ko) * | 1999-07-22 | 2002-03-20 | 데이비드 엠 모이어 | 입체적으로 보호된 에피토프 영역을 갖는 프로테아제콘쥬게이트 |
AU5928100A (en) | 1999-07-22 | 2001-02-13 | Procter & Gamble Company, The | Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions |
MXPA02000840A (es) | 1999-07-22 | 2002-07-30 | Procter & Gamble | Variantes de proteasa de subtilisina que tienen substituciones de aminoacidos en regiones de epitopes definidas. |
US6946128B1 (en) | 1999-07-22 | 2005-09-20 | The Procter & Gamble Company | Protease conjugates having sterically protected epitope regions |
CZ2002171A3 (cs) | 1999-07-22 | 2002-06-12 | The Procter & Gamble Company | Proteinázový konjugát, čistící prostředek a prostředek osobní péče |
BR0012570A (pt) * | 1999-07-22 | 2002-06-04 | Procter & Gamble | Proteases subtilisina intramolecularmente reticuladas com imunogenicidade reduzida |
AU2001254622A1 (en) * | 2000-04-28 | 2001-11-12 | Novozymes A/S | Laccase mutants |
KR20030037267A (ko) | 2000-07-28 | 2003-05-12 | 헨켈 코만디트게젤샤프트 아우프 악티엔 | 바실러스속 a 7-7 (dsm 12368) 에서 추출한신규한 아밀분해 효소 및 상기 신규한 아밀분해 효소를함유하는 세척 및 세정제 |
DE60144399D1 (de) * | 2000-10-02 | 2011-05-19 | Danisco Us Inc | Methode zur bestimmung der immunogenität von proteinen, die eine veränderte immunantwort hervorrufen |
US6673580B2 (en) | 2000-10-27 | 2004-01-06 | Genentech, Inc. | Identification and modification of immunodominant epitopes in polypeptides |
ZA200305980B (en) * | 2001-02-12 | 2007-01-31 | Res Dev Foundation | Modified proteins, designer toxins, and methods of making thereof |
CN100489094C (zh) | 2001-03-23 | 2009-05-20 | 金克克国际有限公司 | 具有改变的免疫原性反应的蛋白质及制备和使用该蛋白质的方法 |
WO2002079415A2 (en) | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
WO2003020761A1 (en) * | 2001-09-04 | 2003-03-13 | Merck Patent Gmbh | Modified human growth hormone |
AU2002353178C1 (en) * | 2001-12-31 | 2011-02-03 | Genencor International, Inc. | Proteases producing an altered immunological response and methods of making and using the same |
BR0215383A (pt) | 2001-12-31 | 2006-11-28 | Genencor Int | proteases que produzem resposta imunogênica alterada e métodos de fabricação e uso das mesmas |
WO2003096869A2 (en) * | 2002-05-16 | 2003-11-27 | Alk Abelló A/S | Recombinant bet. v. 1. allergen mutants, methods and process thereof |
KR101211445B1 (ko) | 2002-07-30 | 2012-12-12 | 다니스코 유에스 인크. | 에어로졸 발생을 감소시킨 제형물 |
WO2004014938A2 (en) * | 2002-08-09 | 2004-02-19 | Xencor | Thrombopoiesis-stimulating proteins having reduced immunogenicity |
WO2004031378A2 (en) | 2002-10-01 | 2004-04-15 | Novozymes A/S | Family gh 61 polypeptides |
EP2500423B1 (en) | 2003-02-26 | 2015-06-17 | Danisco US Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
JP2006513709A (ja) | 2003-02-26 | 2006-04-27 | ジェネンコー・インターナショナル・インク | 修飾されたアミラーゼ免疫反応を示すアミラーゼ変異体、及び、これらの製造方法並びに用途 |
EP1639107B1 (en) | 2003-06-19 | 2013-08-14 | Novozymes A/S | Improved proteases and methods for producing them |
DE602004027376D1 (de) | 2003-06-19 | 2010-07-08 | Novozymes As | Proteasen |
DE602004030595D1 (de) | 2003-10-10 | 2011-01-27 | Novozymes As | Proteasevarianten |
BRPI0415457A (pt) | 2003-10-16 | 2006-12-05 | Micromet Ag | constructo de ligação especìfico de cd3 citotoxicamente ativo, seu processo de produção, composição compreendendo o mesmo, seqüência de ácido nucléico, vetor, hospedeiro, seus usos na preparação de uma composição farmacêutica e kit compreendendo os mesmo |
EP1709165B1 (en) | 2004-01-06 | 2014-04-23 | Novozymes A/S | Polypeptides of alicyclobacillus |
WO2005070967A2 (en) | 2004-01-22 | 2005-08-04 | Merck Patent Gmbh | Anti-cancer antibodies with reduced complement fixation |
EP1735433B1 (en) | 2004-04-02 | 2010-12-08 | Novozymes A/S | Subtilase variants having altered immunogenicity |
WO2005123911A2 (en) | 2004-06-21 | 2005-12-29 | Novozymes A/S | Proteases |
EP1809747B1 (en) | 2004-10-04 | 2016-12-14 | Novozymes A/S | Polypeptides having phytase activity and polynucleotides encoding same |
AR050895A1 (es) | 2004-10-04 | 2006-11-29 | Novozymes As | Polipeptidos que tienen actividad de fitasa y polinucleotidos que los codifican |
EP1920052A2 (en) | 2005-08-16 | 2008-05-14 | Novozymes A/S | Polypeptides of strain bacillus sp. p203 |
US8236308B2 (en) | 2005-10-11 | 2012-08-07 | Micromet Ag | Composition comprising cross-species-specific antibodies and uses thereof |
EP1960517A2 (en) | 2005-12-06 | 2008-08-27 | Genencor International, Inc. | Perhydrolase epitopes |
PL1976880T3 (pl) | 2005-12-21 | 2017-01-31 | Amgen Research (Munich) Gmbh | Kompozycje farmaceutyczne odporne na rozpuszczalny cea |
CN101351477B (zh) | 2005-12-30 | 2011-11-16 | 默克专利有限公司 | 具有降低的免疫原性的抗cd19抗体 |
PL1966238T3 (pl) | 2005-12-30 | 2012-09-28 | Merck Patent Gmbh | Warianty interleukiny-12p40 o polepszonej stabilności |
WO2007107573A1 (en) | 2006-03-22 | 2007-09-27 | Novozymes A/S | Use of polypeptides having antimicrobial activity |
EP2001999B1 (en) | 2006-04-04 | 2012-05-16 | Novozymes A/S | Phytase variants |
CN105112386A (zh) | 2006-12-21 | 2015-12-02 | 诺维信公司 | 用于药物用途的脂肪酶变体 |
US8221743B2 (en) | 2006-12-22 | 2012-07-17 | Novozymes A/S | Use of polypeptides against diseases caused by protozoans |
MX289945B (es) | 2007-03-26 | 2011-09-05 | Novozymes As | Fitasa de hafnia. |
BRPI0919314A2 (pt) | 2008-09-26 | 2015-08-11 | Novozymes As | Fitase, métodos para produzir um variante de fitase e um produto de fermentacao, para melhorar o valor nutricional de uma ração animal, e para o tratamento de proteínas vegetais, sequência isolada de ácidos nucleicos, construto de acido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, microorganismo transgênico, ou produtos, ou elementos destes, composição, processo para reduzir níveis de fitato em extrume de animal, e, uso da fitase. |
MX2011011044A (es) | 2009-04-22 | 2011-11-04 | Merck Patent Gmbh | Proteinas de fusion de anticuerpos con sitios de enlace de receptor fc neonatal (fcrn) modificados. |
MX2012005164A (es) | 2009-11-05 | 2012-10-03 | Cephalon Australia Pty Ltd | Tratamiento de cancer que involucra genes kras o braf mutados. |
WO2012119989A2 (en) | 2011-03-04 | 2012-09-13 | Oryzon Genomics, S.A. | Methods and antibodies for the diagnosis and treatment of cancer |
EP3227341A1 (en) | 2014-12-02 | 2017-10-11 | CeMM - Forschungszentrum für Molekulare Medizin GmbH | Anti-mutant calreticulin antibodies and their use in the diagnosis and therapy of myeloid malignancies |
KR20230050402A (ko) | 2020-08-13 | 2023-04-14 | 노보자임스 에이/에스 | 피타제 변이체 및 이를 암호화하는 폴리뉴클레오티드 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3903068A (en) * | 1972-12-26 | 1975-09-02 | Us Health Education & Welfare | Facile synthesis of human insulin by modification of porcine insulin |
DK6488D0 (da) * | 1988-01-07 | 1988-01-07 | Novo Industri As | Enzymer |
DK316989D0 (da) * | 1989-06-26 | 1989-06-26 | Novo Nordisk As | Enzymer |
-
1991
- 1991-12-05 DE DE69130113T patent/DE69130113T2/de not_active Revoked
- 1991-12-05 WO PCT/DK1991/000382 patent/WO1992010755A1/en active IP Right Grant
- 1991-12-05 KR KR1019930701690A patent/KR100237968B1/ko not_active IP Right Cessation
- 1991-12-05 CA CA002331936A patent/CA2331936C/en not_active Expired - Lifetime
- 1991-12-05 BR BR919107206A patent/BR9107206A/pt not_active IP Right Cessation
- 1991-12-05 AU AU90528/91A patent/AU9052891A/en not_active Abandoned
- 1991-12-05 JP JP50164192A patent/JP3355186B2/ja not_active Expired - Lifetime
- 1991-12-05 AT AT92900779T patent/ATE170630T1/de not_active IP Right Cessation
- 1991-12-05 DK DK92900779T patent/DK0561907T3/da active
- 1991-12-05 CA CA002095852A patent/CA2095852C/en not_active Expired - Lifetime
- 1991-12-05 EP EP92900779A patent/EP0561907B1/en not_active Revoked
-
1993
- 1993-06-04 FI FI932561A patent/FI932561A0/fi not_active Application Discontinuation
-
2001
- 2001-07-16 JP JP2001215943A patent/JP3450840B2/ja not_active Expired - Lifetime
-
2002
- 2002-12-04 JP JP2002352804A patent/JP2003174871A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0561907A1 (en) | 1993-09-29 |
ATE170630T1 (de) | 1998-09-15 |
JP3355186B2 (ja) | 2002-12-09 |
WO1992010755A1 (en) | 1992-06-25 |
JP2002101880A (ja) | 2002-04-09 |
DE69130113T2 (de) | 1999-05-12 |
DE69130113D1 (de) | 1998-10-08 |
CA2331936C (en) | 2007-07-31 |
KR930703610A (ko) | 1993-11-30 |
JPH06502994A (ja) | 1994-04-07 |
DK0561907T3 (da) | 1999-05-31 |
CA2331936A1 (en) | 1992-06-06 |
EP0561907B1 (en) | 1998-09-02 |
BR9107206A (pt) | 1993-11-03 |
KR100237968B1 (ko) | 2000-01-15 |
AU9052891A (en) | 1992-07-08 |
JP3450840B2 (ja) | 2003-09-29 |
CA2095852C (en) | 2001-05-08 |
JP2003174871A (ja) | 2003-06-24 |
CA2095852A1 (en) | 1992-06-06 |
FI932561A (fi) | 1993-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI932561A0 (fi) | Proteiner med foeraendrade epitoper och foerfaranden foer deras framstaellning | |
FI941199A0 (fi) | Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset | |
DE69021002D1 (de) | Schimärische Hepadnavirus-Kernantigenproteine. | |
FI972945A (fi) | Antigeenien antamiseen soveltuvia koostumuksia | |
BR9500732B8 (pt) | Kit diagnóstico para a detecção de anticorpos contra vírus que causam imunodeficiência. | |
PT97159A (pt) | Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina | |
ATE68826T1 (de) | Verfahren zur herstellung von reifem, menschlichem serum-albumin. | |
ES2013328A6 (es) | Un metodo para detectar anticuerpos contra antigenos hiv-1. | |
DE69231663T2 (de) | Polysaccharid-protein-konjugate | |
FI931393A0 (fi) | Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus | |
BG97123A (bg) | Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа | |
CA2178635A1 (en) | Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form | |
FR2692282B1 (fr) | Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications. | |
FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. | |
NO900758L (no) | Fremgangsmaate for fremstilling av hybridprotein. | |
DK0471718T3 (da) | Paracetamolholdigt farmaceutisk præparat | |
FR2624854B1 (fr) | Nouveaux sulfonamides du benzylidene camphre derivant d'aminoacides et leur application en cosmetique, notamment en tant que filtres solaires | |
DK13087D0 (da) | Gensekvens til fremstilling af human serumalbumin i bacillus | |
NO881942D0 (no) | Fremgangsmaate for fremstilling av fremmede proteiner i streptomyceten. | |
DE68922896D1 (de) | RHOPTRY-MEMBRAN-ANTIGEN VON -i(PLASMODIUM FALCIPARUM). | |
ATE175357T1 (de) | Empfängnisverhütender impfstoff | |
ITFI920071A1 (it) | Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk | |
FR2363603A1 (fr) | Compositions de polyterephtalate d'alkylene et d'ester sulfonique, cristallisant rapidement | |
IT8620596V0 (it) | Lenti sovrapponibili per variare l'intensita' dell'assorbimento di luce degli occhiali. | |
IT8821726A0 (it) | Stampo per l'esecuzione di prodotti con porzioni ad elevata resistenza lumgo direzioni preferenziali,in particolare per lenti intraoculari |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused | ||
FCK | Appeal rejected |
Free format text: APPLICATION REJECTED |